In Phase I / Bioequivalence

PharmaNet offers a comprehensive range of clinical development and consulting services for early stage programs, including Phase I and bioequivalence studies. PharmaNet conducts early stage programs for international sponsors through our global network of resources.

Overview

 

Anapharm is an industry leader in early-phase drug development, providing a wide range of services to the pharmaceutical, biotechnology, and generic-drug industries. Anapharm offers a vast array of services in Phase I clinical development, bioequivalence, regulatory affairs, and bioanalytical laboratory analyses. Anapharm clinics may be contacted at:

 

Anapharm Toronto
4101 Yonge Street, Suite 600
Toronto, ON Canada M2P 1N6

P.O. Box 222
Tel: 416 227 1512

Toll free: 800 831 4001
Fax: 416 227 1502

earlystage@pharmanet.com

 

Anapharm Montréal
5160, boul. Décarie
Montréal (Qc) Canada H3X 2H9
Tel: 514 485 7500

Toll free: 800 831 4001
Fax: 514 485 7501

earlystage@pharmanet.com

 

Anapharm Québec
Head Office

2500, rue Einstein
Québec (Qc) Canada G1P 0A2
Tel: 418 527 4000

Toll free: 800 831 4001
Fax: 418 527 3456

earlystage@pharmanet.com


PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390